Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagar N Doshi

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 11, 2014
Feasibility and efficacy of the 2.5 L and 3.8 L impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosisJon Spiro, Vinod Venugopal, Yogesh Raja, et al.
European Heart Journal. Cardiovascular Imaging|October 27, 2015
Transcatheter pulmonary and tricuspid valve-in-valve replacement for bioprosthesis degeneration in carcinoid heart diseaseJamal N Khan, Sagar N Doshi, Stephen J Rooney, et al.
International Journal of Cardiology|April 15, 2026
Temporal trends in causes, management and outcomes of cardiac tamponade complicating TAVI: A 12-year single-center experienceHossameldin Hussein, Ahmed Elsherif, Anthony Mechery, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 24, 2004
Treatment of coronary heart disease with folic acid: is there a future?Stuart J Moat, Sagar N Doshi, Derek Lang, et al.
Cardiology and Therapy|December 18, 2014
Percutaneous Mechanical Ventricular Support in Acute Cardiac Care: A UK Quaternary Centre Experience Using 2.5L, 3.8L and 5.0L Impella CathetersVinod Venugopal, Jon Spiro, Alex Zaphiriou, et al.
International Journal of Cardiology|April 20, 2004
Short-term high-dose folic acid does not alter markers of endothelial cell damage in patients with coronary heart diseaseSagar N Doshi, Stuart J Moat, Malcolm J Lewis, et al.
Journal of Medical Economics|January 11, 2013
The cost-effectiveness of a new percutaneous ventricular assist device for high-risk PCI patients: mid-stage evaluation from the European perspectiveJohanna B Roos, Sagar N Doshi, Thomas Konorza, et al.
Clinical Case Reports|June 30, 2025
Successful Surgical Management of a Coincidence of Three-Vessel Coronary Artery Disease, Severe Carotid Atherosclerosis, and Carotid Paraganglioma: A Case Report and Literature ReviewPouya Ebrahimi, Tooba Akbari, Aysan Nozheh, et al.
The American Journal of Cardiology|December 17, 2003
A comparative study of rotational atherectomy in acute and stable coronary syndromes in the modern eraSagar N Doshi, Annapoorna Kini, Michael C Kim, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 14, 2017
A feasibility study of transaxillary TAVI with the lotus valveSagar N Doshi, Sudhakar George, Chun Shing Kwok, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 11, 2014
Feasibility and efficacy of the 2.5 L and 3.8 L impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosisJon Spiro, Vinod Venugopal, Yogesh Raja, et al.
European Heart Journal. Cardiovascular Imaging|October 27, 2015
Transcatheter pulmonary and tricuspid valve-in-valve replacement for bioprosthesis degeneration in carcinoid heart diseaseJamal N Khan, Sagar N Doshi, Stephen J Rooney, et al.
International Journal of Cardiology|April 15, 2026
Temporal trends in causes, management and outcomes of cardiac tamponade complicating TAVI: A 12-year single-center experienceHossameldin Hussein, Ahmed Elsherif, Anthony Mechery, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 24, 2004
Treatment of coronary heart disease with folic acid: is there a future?Stuart J Moat, Sagar N Doshi, Derek Lang, et al.
Cardiology and Therapy|December 18, 2014
Percutaneous Mechanical Ventricular Support in Acute Cardiac Care: A UK Quaternary Centre Experience Using 2.5L, 3.8L and 5.0L Impella CathetersVinod Venugopal, Jon Spiro, Alex Zaphiriou, et al.
International Journal of Cardiology|April 20, 2004
Short-term high-dose folic acid does not alter markers of endothelial cell damage in patients with coronary heart diseaseSagar N Doshi, Stuart J Moat, Malcolm J Lewis, et al.
Journal of Medical Economics|January 11, 2013
The cost-effectiveness of a new percutaneous ventricular assist device for high-risk PCI patients: mid-stage evaluation from the European perspectiveJohanna B Roos, Sagar N Doshi, Thomas Konorza, et al.
Clinical Case Reports|June 30, 2025
Successful Surgical Management of a Coincidence of Three-Vessel Coronary Artery Disease, Severe Carotid Atherosclerosis, and Carotid Paraganglioma: A Case Report and Literature ReviewPouya Ebrahimi, Tooba Akbari, Aysan Nozheh, et al.
The American Journal of Cardiology|December 17, 2003
A comparative study of rotational atherectomy in acute and stable coronary syndromes in the modern eraSagar N Doshi, Annapoorna Kini, Michael C Kim, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 14, 2017
A feasibility study of transaxillary TAVI with the lotus valveSagar N Doshi, Sudhakar George, Chun Shing Kwok, et al.
Pageof 8